Prothena Corp Public (PRTA) Tax Provisions (2012 - 2026)
Prothena Corp Public (PRTA) recorded quarterly Tax Provisions of $1000.0 in Q1 2026, down 90.0% quarter-over-quarter from $10000.0 in Q4 2025, and up 100.08% on a YoY basis from $499.79 in Q1 2025.
Prothena Corp Public (PRTA) Tax Provisions (2012 - 2026) Analysis & Trends
Prothena Corp Public's Tax Provisions history runs 15 years deep, the most recent figure standing at $1000.0 for Q1 2026.
- In Q1 2026, Tax Provisions rose 100.08% year-over-year to $1000.0; the TTM figure through Mar 2026 stood at $44.4 million (up 902.69% YoY), while the FY2025 annual figure was $43.3 million, up 753.52% from the prior year.
- Tax Provisions was $1000.0 for Q1 2026 at Prothena Corp Public, down from $10000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $44.8 million in Q2 2025 to a low of -$4.3 million in Q2 2023.
- Historically, Tax Provisions has averaged $856058.8 across 5 years, with a median of -$1.7 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Tax Provisions sank 5194.12% in 2022, then surged 2340.1% in 2025.
- A 5-year view of Tax Provisions shows it stood at -$3.0 million in 2022, then declined by 4.93% to -$3.2 million in 2023, then jumped by 51.78% to -$1.5 million in 2024, then surged by 100.66% to $10000.0 in 2025, then slumped by 90.0% to $1000.0 in 2026.
- The last three Tax Provisions figures came in at $1000.0 (Q1 2026), $10000.0 (Q4 2025), and -$400000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | -400,000.00 |
| Jun 30, 2025 | 44.80 Mn |
| Mar 31, 2025 | -1.18 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Sep 30, 2024 | -835,000.00 |
| Jun 30, 2024 | -2.00 Mn |
| Mar 31, 2024 | -2.20 Mn |
| Dec 31, 2023 | -3.15 Mn |
| Sep 30, 2023 | -3.10 Mn |
| Jun 30, 2023 | -4.30 Mn |
| Mar 31, 2023 | -2.90 Mn |
| Dec 31, 2022 | -3.00 Mn |
| Sep 30, 2022 | -2.70 Mn |
| Jun 30, 2022 | -1.30 Mn |
| Mar 31, 2022 | -1.67 Mn |
| Dec 31, 2021 | 83,000.00 |
| Sep 30, 2021 | -51,000.00 |
| Jun 30, 2021 | 300,000.00 |